Aier Eye Financials
| 300015 Stock | 12.42 0.04 0.32% |
| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Operating Income | 6.7 B | 6.4 B |
|
|
Aier | Select Account or Indicator |
Understanding current and past Aier Eye Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Aier Eye's financial statements are interrelated, with each one affecting the others. For example, an increase in Aier Eye's assets may result in an increase in income on the income statement.
Please note, the presentation of Aier Eye's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Aier Eye's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Aier Eye's management manipulating its earnings.
Aier Eye Stock Summary
Aier Eye competes with Juneyao Airlines, GRG Banking, Financial Street, Jinhui Mining, and Guocheng Mining. Aier Eye is entity of China. It is traded as Stock on SHE exchange.Specialization | Health Care, Health Care Equipment & Services |
| Instrument | China Stock View All |
| Exchange | Shenzhen Stock Exchange |
| ISIN | CNE100000GR6 |
| Business Address | No 188 Aier |
| Sector | Health Care Providers & Services |
| Industry | Health Care |
| Benchmark | Dow Jones Industrial |
| Website | www.aierchina.com |
| Phone | 86 731 8517 4163 |
You should never invest in Aier Eye without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Aier Stock, because this is throwing your money away. Analyzing the key information contained in Aier Eye's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
Aier Eye Key Financial Ratios
Aier Eye's financial ratios allow both analysts and investors to convert raw data from Aier Eye's financial statements into concise, actionable information that can be used to evaluate the performance of Aier Eye over time and compare it to other companies across industries.| Revenue | 20.37 B | ||||
| Gross Profit | 10.33 B | ||||
| EBITDA | 5.56 B | ||||
| Net Income | 3.36 B | ||||
| Total Asset | 30.19 B |
Aier Eye Key Balance Sheet Accounts
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Total Assets | 15.5B | 21.8B | 26.6B | 30.2B | 34.7B | 36.5B | |
| Other Current Liab | 1.0B | 2.4B | 2.6B | 2.3B | 2.7B | 2.8B | |
| Other Liab | 294.5M | 357.7M | 172.2M | 194.4M | 223.6M | 186.3M | |
| Net Debt | (980.9M) | 1.1B | (1.4B) | (499.0M) | (449.1M) | (471.6M) | |
| Retained Earnings | 2.8B | 4.3B | 6.0B | 8.4B | 9.6B | 10.1B | |
| Accounts Payable | 1.5B | 1.4B | 1.5B | 1.9B | 2.2B | 2.3B | |
| Cash | 3.1B | 4.4B | 6.0B | 6.1B | 7.0B | 7.4B | |
| Long Term Debt | 1.4B | 57.7M | 115.1M | 22.2M | 25.5M | 24.2M | |
| Net Receivables | 1.7B | 1.9B | 1.9B | 2.3B | 2.6B | 2.7B | |
| Inventory | 494.6M | 571.3M | 731.0M | 899.7M | 1.0B | 1.1B | |
| Other Current Assets | 46.4M | 78.9M | 124.8M | 117.7M | 135.3M | 84.6M | |
| Total Liab | 4.9B | 9.6B | 9.0B | 10.2B | 11.7B | 12.3B | |
| Total Current Assets | 5.6B | 7.2B | 9.7B | 10.2B | 11.7B | 12.3B | |
| Intangible Assets | 545.7M | 751.4M | 813.8M | 828.1M | 952.3M | 1000.0M | |
| Common Stock | 4.1B | 5.4B | 7.2B | 9.3B | 10.7B | 11.3B | |
| Good Will | 3.9B | 4.3B | 5.5B | 6.5B | 7.5B | 7.9B | |
| Short Term Debt | 700.3M | 2.3B | 1.1B | 1.6B | 1.9B | 2.0B | |
| Net Tangible Assets | 3.1B | 3.4B | 5.4B | 6.2B | 7.2B | 3.9B | |
| Short Long Term Debt | 487.1M | 671.4M | 573.0M | 850.4M | 977.9M | 512.0M | |
| Net Invested Capital | 11.7B | 12.0B | 17.4B | 19.7B | 22.7B | 13.1B | |
| Net Working Capital | 2.3B | 939.3M | 4.3B | 4.2B | 4.8B | 2.5B |
Aier Eye Key Income Statement Accounts
An income statement is very similar to a cash flow statement, but instead of showing net revenue minus expenses, it only includes earnings before interest and taxes (EBIT). This number does not have all of the same line items that are on a cash flow statement, but it leaves out non-cash expenses like depreciation and amortization. For example, if you bought $100 worth of goods from Walmart (WMT) using your debit card that has an interest rate of 20%, then paid off the balance at the end of the month with a credit card that charges 30% interest, you would have an income statement showing EBIT of $80 because your expenses are lower than the amount that went into your pocket.
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Interest Expense | 75.4M | 164.7M | 177.6M | 194.8M | 224.0M | 235.2M | |
| Total Revenue | 11.9B | 15.0B | 16.1B | 20.4B | 23.4B | 24.6B | |
| Operating Income | 3.4B | 4.2B | 4.0B | 5.5B | 6.4B | 6.7B | |
| Cost Of Revenue | 5.8B | 7.2B | 8.0B | 10.0B | 11.5B | 12.1B | |
| Income Before Tax | 2.4B | 3.1B | 3.3B | 4.6B | 5.2B | 5.5B | |
| Net Income | 1.7B | 2.3B | 2.5B | 3.4B | 3.9B | 4.1B | |
| Income Tax Expense | 314.4M | 409.1M | 486.1M | 677.9M | 779.5M | 818.5M | |
| Minority Interest | 798.3M | (146.6M) | (164.8M) | (297.1M) | (267.4M) | (254.0M) | |
| Research Development | 164.2M | 222.5M | 271.7M | 333.5M | 383.5M | 402.7M | |
| Gross Profit | 6.1B | 7.8B | 8.1B | 10.3B | 11.9B | 12.5B | |
| Ebit | 1.7B | 2.3B | 3.3B | 4.0B | 4.6B | 4.9B | |
| Tax Provision | 486.1M | 677.9M | 646.1M | 895.0M | 1.0B | 519.7M | |
| Net Interest Income | (69.0M) | (149.3M) | (135.6M) | (126.0M) | (113.4M) | (119.1M) | |
| Interest Income | 38.8M | 58.4M | 87.6M | 119.2M | 137.1M | 143.9M | |
| Ebitda | 2.3B | 2.9B | 4.3B | 4.7B | 5.4B | 3.1B |
Aier Eye Key Cash Accounts
Cash flow analysis captures how much money flows into and out of Aier Eye Hospital. It measures of how well Aier is doing because it can show the actual money that comes into and out of the Company from sales instead of measuring expenses against revenue to determine earnings. You have to read the cash flow statement in three sections. The first section shows how much money Aier Eye brought in, usually known as net revenue or sales. This is different from earnings because it does not include expenses when determining net revenue for use on this part of the cash flow statement. Next, are operating activities, which show how much money Aier had leftover after paying for its expenses. This number can be calculated in two ways: by subtracting the total of all operating expenses from net revenue or by adding up changes to cash and other assets or liabilities on this part of the statement. The third section is about investing activities, which shows what Aier Eye has done with the money that it received from the sale of assets or what it spent to acquire new ones. This section can be broken down into two parts: investing in existing businesses (in other words, buying more stock) and investing in non-business activities like paying off debt or making acquisitions.
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Dividends Paid | 530.7M | 662.5M | 672.6M | 746.9M | 858.9M | 901.9M | |
| Capital Expenditures | 893.7M | 1.5B | 1.4B | 1.5B | 1.7B | 1.8B | |
| Net Income | 1.7B | 2.3B | 2.5B | 3.4B | 3.9B | 4.1B | |
| Change To Inventory | (38.9M) | (37.6M) | (159.5M) | (168.6M) | (151.8M) | (144.2M) | |
| Investments | (317.2M) | (250.3M) | (3.3B) | (3.3B) | (3.0B) | (2.8B) | |
| Change In Cash | 1.4B | 1.3B | 1.6B | 92.6M | 106.5M | 101.1M | |
| Net Borrowings | (92.9M) | 798.0M | (435.2M) | (449.8M) | (404.8M) | (384.6M) | |
| Depreciation | 415.9M | 937.5M | 1.2B | 1.3B | 1.5B | 1.6B | |
| Change To Netincome | 293.1M | 439.5M | 931.7M | 896.8M | 1.0B | 1.1B | |
| End Period Cash Flow | 3.0B | 4.3B | 6.0B | 6.1B | 7.0B | 7.3B | |
| Free Cash Flow | 2.4B | 2.6B | 3.1B | 4.4B | 5.1B | 5.3B | |
| Other Non Cash Items | 231.1M | 294.9M | 272.8M | 460.7M | 529.8M | 276.4M |
Aier Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Aier Eye's current stock value. Our valuation model uses many indicators to compare Aier Eye value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Aier Eye competition to find correlations between indicators driving Aier Eye's intrinsic value. More Info.Aier Eye Hospital is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers reporting about 0.53 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Aier Eye Hospital is roughly 1.90 . Comparative valuation analysis is a catch-all model that can be used if you cannot value Aier Eye by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Aier Eye's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.Aier Eye Hospital Systematic Risk
Aier Eye's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Aier Eye volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The function did not generate any output. Please change time horizon or modify your input parameters. The output start index for this execution was one with a total number of output elements of sixty. The Beta measures systematic risk based on how returns on Aier Eye Hospital correlated with the market. If Beta is less than 0 Aier Eye generally moves in the opposite direction as compared to the market. If Aier Eye Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Aier Eye Hospital is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Aier Eye is generally in the same direction as the market. If Beta > 1 Aier Eye moves generally in the same direction as, but more than the movement of the benchmark.
Aier Eye Hospital Total Assets Over Time
Aier Eye Thematic Clasifications
Aier Eye Hospital is part of Health Management investing theme. If you are a theme-oriented, socially responsible, and at the same time, a result-driven investor, you can align your investing habits with your values without jeopardizing your expectations about returns. You can easily create an optimal portfolio of stocks, ETFs, funds, or cryptocurrencies based on a specific theme of your liking. Healthcare providers, hospitals. Major hospitals and healthcare providers
This theme covers Healthcare providers, hospitals. Major hospitals and healthcare providers. Get More Thematic Ideas
| Health Management | View |
Aier Eye January 19, 2025 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Aier Eye help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Aier Eye Hospital. We use our internally-developed statistical techniques to arrive at the intrinsic value of Aier Eye Hospital based on widely used predictive technical indicators. In general, we focus on analyzing Aier Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Aier Eye's daily price indicators and compare them against related drivers.
| Information Ratio | (0.07) | |||
| Maximum Drawdown | 13.86 | |||
| Value At Risk | (4.00) | |||
| Potential Upside | 4.03 |
Complementary Tools for Aier Stock analysis
When running Aier Eye's price analysis, check to measure Aier Eye's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Aier Eye is operating at the current time. Most of Aier Eye's value examination focuses on studying past and present price action to predict the probability of Aier Eye's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Aier Eye's price. Additionally, you may evaluate how the addition of Aier Eye to your portfolios can decrease your overall portfolio volatility.
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes |